HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review-Reference-Cited by-同舟云学术

HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review

Published:2015-11-26 Issue:6 Volume:17 Page:411-424
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Lambert CT¹,Sandesara PB¹,Hirsh B²,Shaw LJ¹,Lewis W³,Quyyumi AA¹,Schinazi RF⁴,Post WS⁵,Sperling L¹

Affiliation:

1. Division of Cardiology; Department of Medicine; Emory University School of Medicine; Atlanta GA USA

2. Division of Cardiology; Department of Medicine; Mt Sinai School of Medicine; New York NY USA

3. Department of Pathology; Emory University School of Medicine; Atlanta GA USA

4. Department of Pediatrics; Center for AIDS Research; Emory University School of Medicine; Atlanta GA USA

5. Division of Cardiology; Department of Medicine; Johns Hopkins University School of Medicine; Baltimore MD USA

Funder

Center for AIDS Research, Emory University

U.S. Department of Veterans Affairs

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference137 articles.

1. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data - United States and 6 U.S. dependent areas - 2011 Centers for Disease Control and Prevention (CDC)

2. Estimated HIV incidence among adults and adolescents in the United States, 2007-2010

3. Cardiovascular disease in HIV infection;Sudano;Am Heart J,2006

4. Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men;Mateen;Neurology,2013

5. HIV testing among men who have sex with men: 21 cities, United States, 2008

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of death and readmission among individuals with heart failure and HIV: A systematic review and meta-analysis;Journal of Infection and Public Health;2024-01

2. Personalizing Direct Oral Anticoagulant Therapy for a Diverse Population: Role of Race, Kidney Function, Drug Interactions, and Pharmacogenetics;Clinical Pharmacology & Therapeutics;2022-08-04

3. VCAM-1 as a Biomarker of Endothelial Function among HIV-Infected Patients Receiving and Not Receiving Antiretroviral Therapy;Viruses;2022-03-11

4. “Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV”;HIV Medicine;2022-02-24

5. Predicting the risk of atherosclerotic cardiovascular disease among adults living with HIV/AIDS in Addis Ababa, Ethiopia: A hospital-based study;PLOS ONE;2021-11-29